MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance.
P. Sohier
J. Raymond
Zackie Aktary
N. Zidi
Lara Araktingi
N. Charoenchon
Céline Pisibon
Sylvie Caberia
É. Pasmant
Nicolas Macagno
V. Delmas
C. Gaudy-Marqueste
E. Steingrímsson
R. Ballotti
Valérie Petit
Lionel Larue
Medicine